VAERS reports by lot

GSK Varicella/Shingles lot 524S7: VAERS reports

54 VAERS reports list lot 524S7 as a GSK Varicella/Shingles vaccine, received between 2018-07-23 and 2023-10-04. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
54
Reports
2%
Marked serious
0
With a death outcome
11
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)6728%
Injection-site / Local reaction3916%
Musculoskeletal3314%
Neurological3213%
Dermatological (non-injection-site)2611%
Gastrointestinal167%
Allergic / Anaphylactic146%
Cardiac / Cardiovascular104%
Respiratory21%
Psychiatric / Neuropsychiatric21%

Where reports came from

U.S. state of the reporter, where given (top 12).

Pennsylvania5
New York5
South Carolina4
Texas4
California4
Wisconsin3
South Dakota3
New Jersey2
Iowa2
Louisiana2
Florida2
Maryland1

Reports by month received

2018-071
2018-0815
2018-0917
2018-105
2018-115
2018-123
2019-013
2019-022
2019-071
2019-091
2023-101

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.